ストックスクリーナーアプリを入手
1.68
6.15%
-0.11
プレマーケット:
1.65
-0.03
-1.79%
前日終値:
$1.79
開ける：
$1.8
24時間の取引高:
160.68K
Relative Volume:
0.13
時価総額：
$20.49M
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
-15.15%
1か月 パフォーマンス:
-36.84%
6か月 パフォーマンス:
-36.84%
1年 パフォーマンス:
-95.32%
1日の値動き範囲:
$1.64
$1.8399
1週間の範囲:
$1.5685
$2.0799
52週間の値動き範囲:
$1.345
$53.79
Q 32 Bio Inc Stock (QTTB) Company Profile
QTTB を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
QTTB
Q 32 Bio Inc
|
1.68 | 21.83M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
387.77 | 96.01B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
556.55 | 57.86B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
429.93 | 57.02B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
637.56 | 39.10B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.10 | 34.45B | 3.81B | -644.79M | -669.77M | -6.24 |
Q 32 Bio Inc Stock (QTTB) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-02-11 | ダウングレード | BMO Capital Markets | Outperform → Market Perform |
| 2025-02-11 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2024-12-11 | ダウングレード | Guggenheim | Buy → Neutral |
| 2024-12-11 | ダウングレード | Leerink Partners | Outperform → Market Perform |
| 2024-12-11 | ダウングレード | Raymond James | Strong Buy → Outperform |
| 2024-12-11 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2024-12-06 | 開始されました | BMO Capital Markets | Outperform |
| 2024-10-24 | 開始されました | Raymond James | Strong Buy |
| 2024-09-11 | 開始されました | Wells Fargo | Overweight |
| 2024-06-17 | 開始されました | Guggenheim | Buy |
| 2024-05-21 | 開始されました | Leerink Partners | Outperform |
| 2024-04-11 | 開始されました | Oppenheimer | Outperform |
| 2024-04-02 | 開始されました | Piper Sandler | Overweight |
| 2023-07-28 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2022-02-22 | 繰り返されました | BTIG Research | Neutral |
| 2022-02-22 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2022-02-22 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2021-03-02 | 開始されました | Stifel | Hold |
| 2020-12-14 | 再開されました | H.C. Wainwright | Buy |
| 2020-08-11 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-06-25 | 再開されました | BofA/Merrill | Buy |
| 2020-05-13 | 開始されました | RBC Capital Mkts | Outperform |
| 2020-03-16 | アップグレード | Oppenheimer | Perform → Outperform |
| 2020-02-24 | 開始されました | Chardan Capital Markets | Buy |
| 2019-11-01 | 開始されました | Oppenheimer | Perform |
| 2019-09-10 | 開始されました | Robert W. Baird | Outperform |
| 2019-04-12 | 開始されました | Evercore ISI | Outperform |
すべてを表示
Q 32 Bio Inc (QTTB) 最新ニュース
Is Q32 Bio Inc. stock bottoming outWeekly Investment Summary & Growth Oriented Trade Recommendations - Newser
Can trapped investors hope for a rebound in Q32 Bio Inc.Risk Balanced Picks for Safer Trading - Newser
Q32 Bio Inc. stock outlook for YEAR [July 2025 Selloffs]Free Weekly Return Optimization Plans - Newser
How to use Fibonacci retracement on Q32 Bio Inc.Summary of Long-Term Buy Zone Stocks - Newser
What earnings revisions data tells us about Q32 Bio Inc.Buy Strategy Tracker with Growth Indicators - Newser
Should you wait for a breakout in Q32 Bio Inc.Free Triple Return Setup with Risk Control - Newser
Long term hold vs stop loss in Q32 Bio Inc.Free News Based Entry Opportunity Alerts - Newser
Q32 Bio Inc. stock outlook for YEARMarket Ready Picks with Technical Support - Newser
Does Q32 Bio Inc. qualify in momentum factor screeningFree AI Screening for Swing Trade Picks - Newser
Can a trend reversal in Q32 Bio Inc. lead to recoveryFree Trade Scanner With Buy Zone Alerts - Newser
Using portfolio simulators with Q32 Bio Inc. includedMarket Stability and Long-Term Growth Outlook - Newser
Using data tools to time your Q32 Bio Inc. exitBuy Strategy Tracker with Growth Indicators - Newser
How Q32 Bio Inc. stock reacts to Fed policy changesSwing Trade Entry and Exit Point Analysis - Newser
Will Q32 Bio Inc. benefit from rate cutsTop Fast Growth Opportunities - thegnnews.com
Will Q32 Bio Inc. rebound enough to break evenReal-Time AI Generated Market Forecast - Newser
Understanding Q32 Bio Inc.’s price movementTrend Reversal Watch with Entry Signals - Newser
Historical volatility pattern of Q32 Bio Inc. visualizedVolume Based Swing Signal Prediction Map - Newser
Q32 Bio Inc. Reports Continued Losses Amid Development Efforts - TipRanks
Q32 Bio (QTTB) Expected to Announce Quarterly Earnings on Thursday - Defense World
Q32 Bio August 2025 slides: Bempikibart shows durable response in alopecia areata - Investing.com
Q32 Bio: Q2 Earnings Snapshot - The Washington Post
Q32 Bio Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Q32 Bio Inc. SEC 10-Q Report - TradingView
Q32 Bio Secures FDA Fast Track for Alopecia Treatment as Phase 2 Trial Advances with $54.8M Runway - Stock Titan
Intrinsic Value of Q32 Bio Inc. Stock: Is It Undervalued or OvervaluedDaily Pick Forecast with Entry Zones - Newser
Q32 Bio Inc expected to post a loss of 98 cents a shareEarnings Preview - TradingView
Q 32 Bio Inc (QTTB) 財務データ
Q 32 Bio Inc (QTTB) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
Q 32 Bio Inc (QTTB) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Violette Shelia M. | Chief Scientific Officer |
Oct 11 '24 |
Option Exercise |
3.12 |
4,574 |
14,271 |
17,874 |
| Violette Shelia M. | Chief Scientific Officer |
Oct 08 '24 |
Option Exercise |
3.12 |
13,300 |
41,496 |
13,300 |
0.91%
3.06%
大文字化:
|
ボリューム (24 時間):